Research progresses of fibroblast activation protein inhibitor PET imaging for diagnosis of non-malignant diseases
10.13929/j.issn.1003-3289.2023.12.034
- VernacularTitle:成纤维细胞激活蛋白抑制剂PET显像诊断非恶性疾病研究进展
- Author:
Mengting LI
1
,
2
;
Wenzhu HU
;
Xiao ZHANG
;
Chunxia QIN
;
Xiaoli LAN
Author Information
1. 华中科技大学同济医学院附属协和医院核医学科,湖北武汉 430022
2. 湖北省分子影像重点实验室,湖北武汉 430022
- Keywords:
fibroblast activation protein alpha;
positron-emission tomography
- From:
Chinese Journal of Medical Imaging Technology
2023;39(12):1893-1897
- CountryChina
- Language:Chinese
-
Abstract:
Fibroblast activation protein(FAP)can overexpress in activated fibroblasts.In recent years,radiolabeled FAP inhibitor(FAPI)had become important new positron imaging agents in nuclear medicine following 18F-FDG,and increasingly used for non-malignant diseases.The research progresses of FAPI PET imaging for diagnosis of non-malignant diseases were reviewed in this article.
